Digestive Remedies in Brazil
DIGESTIVE REMEDIES IN BRAZIL
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Switches Still Waiting for Approval From Anvisa
Ibs Treatments Remains the Best Performing Category
Marketing Activities and New Delivery Formats Drive Sales of Antacids
Competitive Landscape
Leading Three Companies Together Continue To Dominate Digestive Remedies
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2013-2018
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Digestive Remedies: % Value 2014-2018
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2015-2018
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2018-2023
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Continues To Be One of the Few Industries To Record Positive Growth
Generics Gaining Ground in the OTC Category
Leading Companies Continue To Invest in Marketing Activities To Drive Sales
Internet Retailing Continues To Slowly Gain Share
Further Solid Growth Anticipated Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
ANVISA is expected to approve the switch of certain ingredients which are globally available over the counter, including omeprazole, which falls under proton pump inhibitors and is still sold as a prescription drug in Brazil. Although it is easy to purchase without a prescription, ANVISA is taking its time to consider the switch as several media outlets in late 2017 reported studies linking the frequent usage of omeprazole with a higher risk of cancer.
Euromonitor International's Digestive Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.